Opinion: Bristol Myers Squibb Is a Buy -- but the Real Reason Why Might Surprise Investors
What it is about
Who published it, and when
How it spread - 4 original reports, 2 reprints
Sat, 29 August 2026
1 report- yahoo.com14:35first to report
Bristol Myers Squibb is facing down a major patent cliff, which is a problem and a huge motivating force.
2 reprints
- fool.com29 Aug, 14:15their copy
- aol.com29 Aug, 14:35their copy
Thu, 3 September 2026
1 report- financial-news.co.uk16:18
A report of an AstraZeneca Bristol Myers Squibb merger rattled London’s benchmark on Monday, wiping more than £17 billion off AstraZeneca’s market value and capping the FTSE 100’s advance even as European peers surged on easing geopolitical tensions. AstraZeneca fell around 5%, trimming significant points from the index, which traded flat by mid-morning. Brent crude
Tue, 8 September 2026
1 report- fool.com18:00
Don't catch a falling knife.
Sat, 12 September 2026
1 report- dailypolitical.com02:48
The Manufacturers Life Insurance Company lifted its position in shares of Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 23.2% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 2,176,661 shares of the biopharmaceutical company’s stock after acquiring an additional 410,243 shares during the period. The Manufacturers Life Insurance Company’s holdings in Bristol […]